Dec 12, 2006 – Sydney, Australia Novotech, the largest independent Australian owned contract research organization (CRO) and the only Australian CRO with offices in the USA, announced today that it is a winner in the Deloitte Fast 500 Asia Pacific 2006 Program. The Program run by the leading global consultancy, is supported by the Deloitte Technology... Read more
December 12th, 2006
Novotech recognized in Deloitte Technology Fast 500 Asia Pacific 2006 Program
October 3rd, 2006
Novotech CRO opens second office in the USA
Oct 3, 2006 – Sydney, Australia — Novotech, the largest independent Australian owned contract research organization (CRO) announced today it has accelerated its US expansion plans with the opening of a second office in the USA specifically designed to service the maturing Australian biotech sector. Novotech CEO Alek Safarian said the new office... Read more
June 21st, 2006
Novotech presents checklist for CRO partnering and trials selection in Australia & Asia at DIA 2006
June 21, 2006 – Philadelphia, PA — Novotech, the largest Australian owned contract research organization (CRO) presented to the Drug Industry Association (DIA) annual conference 2006 this week, a check list for the selection of a CRO in Australia and the Asian region. At Novotech’s DIA press conference, Novotech CEO Alek Safarian said all... Read more
June 21st, 2006
Novotech checklist for CRO partnering and trials selection is Australia & Asia
June 21, 2006 – Philadelphia, PA —Size match – ensure the CRO is a good match in organizational size and reach. Make sure the CRO has experience working with companies at a similar stage and growth phase, eg, small to medium sized biotechs often find it frustrating working with the large global CROs as they can struggle with response times... Read more
June 20th, 2006
Novotech wins prestigious Asian CRO of The Year Award
June 20, 2006 – Philadelphia, PA — Novotech, the largest Australian owned contract research organization (CRO) announced today it has been recognized by Frost & Sullivan for its clinical research capabilities at the inaugural Asia Pacific Healthcare Best Practice Awards, winning The Asian CRO of the Year – Australia Award. According... Read more
April 9th, 2006
Novotech’s expansion to USA reaps multimillion
April 9, 2006 – Chigago, Il — Novotech, the largest Australian owned contract research organization (CRO) announced today at BIO 2006 in Chicago Il., an AUD4 million deal with US biotech firm SkyePharma (LSE: SKP; Nasdaq: SKYE) to conduct a key trial required for the US FDA. This is the first major deal for Novotech’s new US operations which... Read more
